These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20419850)
21. Intravitreal pegaptanib sodium for Irvine-Gass syndrome. Querques G; Iaculli C; Delle Noci N Eur J Ophthalmol; 2008; 18(1):138-41. PubMed ID: 18203101 [TBL] [Abstract][Full Text] [Related]
22. Treatment of choroidal neovascularization using intravitreal bevacizumab. Pedersen R; Soliman W; Lund-Andersen H; Larsen M Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757 [TBL] [Abstract][Full Text] [Related]
23. Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization. Forte R; Cennamo G; Finelli M; Cesarano I; D'Amico G; De Crecchio G; Cennamo G Acta Ophthalmol; 2010 Dec; 88(8):e305-10. PubMed ID: 20946332 [TBL] [Abstract][Full Text] [Related]
24. Comparing pegaptanib and triamcinolone efficacy in the rat choroidal neovascularization model. Criswell MH; Hu WZ; Steffens TJ; Li R; Margaron P Arch Ophthalmol; 2008 Jul; 126(7):946-52. PubMed ID: 18625941 [TBL] [Abstract][Full Text] [Related]
25. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288 [TBL] [Abstract][Full Text] [Related]
26. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization. Inoue M; Kadonosono K; Watanabe Y; Sato S; Kobayashi S; Yamane S; Ito R; Arakawa A Retina; 2010 May; 30(5):733-8. PubMed ID: 20168271 [TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Rosenfeld PJ; Moshfeghi AA; Puliafito CA Ophthalmic Surg Lasers Imaging; 2005; 36(4):331-5. PubMed ID: 16156152 [TBL] [Abstract][Full Text] [Related]
28. Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab. Kumar N; Tigari B; Dogra M; Singh R Indian J Ophthalmol; 2018 Sep; 66(9):1358-1360. PubMed ID: 30127172 [TBL] [Abstract][Full Text] [Related]
29. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up. Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA; Retina; 2008; 28(10):1387-94. PubMed ID: 18827735 [TBL] [Abstract][Full Text] [Related]
30. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related]
31. Pro Re Nata Intravitreal Bevacizumab for the Treatment of Idiopathic Choroidal Neovascular Membrane. Saurabh K; Roy R; Panigrahi PK; Lobo A; Majumdar AK Semin Ophthalmol; 2016; 31(5):463-6. PubMed ID: 25392193 [TBL] [Abstract][Full Text] [Related]
32. Pegaptanib sodium for occult choroidal neovascularization in neovascular age-related macular degeneration: a prospective case series. Atmani K; Coscas F; Coscas G; Soubrane G Eye (Lond); 2009 May; 23(5):1150-4. PubMed ID: 18636083 [TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum. Myung JS; Bhatnagar P; Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Freund KB Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818 [TBL] [Abstract][Full Text] [Related]